BioSpace News Archive

TriRx Pharmaceutical Services, LLC, a Contract Development and Manufacturing Organization, welcomed the UK Government’s recent announcement on England’s second Investment Zone, focused on Life Sciences in the Liverpool City Region.

n-Lorem, a nonprofit foundation , outlines the steps the Foundation has taken to support the discovery, development and treatment of nano-rare patients (1-30 patients worldwide), for free, for life.

Accelerate Diagnostics, Inc. announced that management will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. Eastern Time to review 2023 second quarter results.

Co-Diagnostics, Inc. announced today it will release its second quarter 2023 results on Thursday, August 10, 2023, after the market close.

UroGen Pharma Ltd. (Nasdaq: URGN) (UroGen) today announced that it has entered into a definitive securities purchase agreement in connection with a private placement (the Private Placement) to selected institutional and accredited investors.

Universe Pharmaceuticals INC announced that the Company plans to effect a share consolidation of six ordinary shares with par value of $0.003125 per share each in the Company’s issued and unissued share capital into one ordinary share with par value of US$0.01875.

OKYO Pharma Limited (Nasdaq: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, is pleased to announce that it has appointed William A. Clementi, Pharm.D., FCP as Chief Operating Officer.

Eli Lilly and Company announced results of two phase 3 tirzepatide studies in adults with obesity or overweight with weight-related comorbidities, excluding type 2 diabetes.

Fulcrum Therapeutics, Inc. today announced that its second quarter 2023 financial results will be released on Thursday, August 3, 2023 before the U.S. financial markets open.

Kymera Therapeutics, Inc. will report second quarter 2023 financial results on August 3, 2023, and will host a conference call at 8:30 a.m. ET that day.